Skip to content
SID 0015 Entellus Medical: Part 2 episode artwork

Feb 6, 2016 1 hr 20 min

SID 0015 Entellus Medical: Part 2

from Stocks-in-Depth

In part 2 of this stock research podcast discussing Entellus Medical, we explore the rough an tumble world of how rivals in the medical device industry can vary from raising a hundred million dollars for companies that wind up having minimal revenues and fail, to the foibles of industry giants such as Johnson and Johnson, which can be outwitted by small, nimble competitors such as Entellus Medical. We also share with you the lurid side of small companies that raise capital from investors who think new technology can be a panacea, when in reality just a few innovators succeed. Even when a company develops an advance to the industry's state of the art, it isn't a lead-pipe cinch that it wont fall prey to the political leverage a well-connected political contributor and lobbyist might exert to quash treatments that would save money for insurers, improve outcomes for patients, and raise incomes for doctors, as incredible as that may seem to those who unquestionably support either the left or right ends of the political spectrum.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

SID 0015 Entellus Medical: Part 2

0:00 1:20:09

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Stocks-in-Depth?

This episode is 1 hour and 20 minutes long.

When was this Stocks-in-Depth episode published?

This episode was published on February 6, 2016.

Can I download this Stocks-in-Depth episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.